Clinical Trials · NCT00827307
Zoladex Plus Tamoxifen in Breast Cancer
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Zhejiang Cancer Hospital
- Enrollment
- 100
- Start date
- Jun 2008
- Locations
- 1 site, China
- Primary endpoint
- Mammographic percentage density at 18months